Cogent Biosciences Ownership | Who Owns Cogent Biosciences?

Cogent Biosciences Ownership Summary

Cogent Biosciences is owned by 118.38% institutional investors, 0.04% insiders. Fmr is the largest institutional shareholder, holding 19.58% of COGT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.91% of its assets in Cogent Biosciences shares.

COGT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cogent Biosciences	118.38%	0.04%	-18.42%
Sector	Healthcare Stocks	492.67%	11.09%	-403.76%
Industry	Biotech Stocks	295.31%	11.22%	-206.53%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	22.41M	19.58%	$321.78M
Blackrock funding, inc. /de	10.37M	9.06%	$148.91M
Kynam capital management, lp	8.49M	7.42%	$60.98M
Blackrock	7.29M	7.34%	$61.44M
Vanguard group	7.76M	6.78%	$111.40M
Commodore capital lp	6.88M	6.25%	$53.68M
Tcg crossover management	6.96M	6.08%	$50.00M
Fairmount funds management	6.23M	5.44%	$44.70M
Paradigm biocapital advisors lp	4.92M	4.46%	$38.36M
Point72 asset management	4.91M	4.29%	$35.27M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
New leaf venture partners	250.76K	8.37%	$3.60M
Superstring capital management lp	962.95K	8.19%	$6.91M
Saturn v capital management	2.30M	6.69%	$16.50M
Kynam capital management, lp	8.49M	6.56%	$60.98M
Fairmount funds management	6.23M	5.79%	$44.70M
Tcg crossover management	6.96M	5.71%	$50.00M
Commodore capital lp	6.88M	3.93%	$53.68M
Octagon capital advisors lp	2.76M	3.55%	$21.55M
Vr adviser	4.76M	2.56%	$34.14M
Exome asset management	533.65K	2.42%	$3.83M

Top Buyers

Holder	Shares	% Assets	Change
Fmr	22.41M	0.02%	5.33M
Blackrock funding, inc. /de	10.37M	0.00%	1.74M
Octagon capital advisors lp	2.76M	3.55%	1.46M
Vanguard group	7.76M	0.00%	1.23M
Ikarian capital	1.04M	1.43%	1.04M

Top Sellers

Holder	Shares	% Assets	Change
Adage capital partners gp	-	-	-4.30M
Logos global management lp	-	-	-2.00M
Redmile group	1.45M	1.11%	-1.77M
Ubs group	1.85M	0.00%	-1.66M
Millennium management	56.51K	0.00%	-1.56M

New Positions

Holder	Shares	% Assets	Change	Value
Ikarian capital	1.04M	1.43%	1.04M	$7.44M
Silverarc capital management	815.08K	1.58%	815.08K	$11.70M
Rock springs capital management lp	800.20K	0.36%	800.20K	$5.75M
Marshall wace, llp	642.48K	0.01%	642.48K	$9.23M
Boothbay fund management	502.00K	0.07%	502.00K	$3.60M

Sold Out

Holder	Change
National bank of canada /fi/	-1.00
Clear point advisors	-1.00
Cbiz investment advisory services	-3.00
Ifp advisors	-8.00
Nelson, van denburg & campbell wealth management group	-16.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	191	5.52%	135,507,980	6.74%	118	0.94%	104	8.33%	40	-16.67%
Mar 31, 2025	184	1.10%	133,476,565	9.67%	117	0.97%	98	-	48	2.13%
Dec 31, 2024	179	9.15%	120,758,047	-0.89%	109	0.90%	96	12.94%	48	4.35%
Sep 30, 2024	161	6.62%	121,811,557	0.36%	110	0.74%	84	6.33%	46	-4.17%
Jun 30, 2024	151	-3.21%	121,368,548	11.09%	122	0.92%	79	-20.20%	48	37.14%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	4.06M	2.91%	592.96K
Vanguard US Total Market Shares ETF	3.09M	2.71%	-
Fidelity Select Health Care	3.38M	2.42%	238.90K
Fidelity Advisor Biotechnology I	2.58M	1.85%	581.61K
Fidelity Small Cap Growth	2.57M	1.84%	-
iShares Russell 2000 ETF	2.57M	1.84%	-
FIAM Small Cap Core Composite	1.87M	1.69%	225.12K
Fidelity Advisor Health Care I	1.90M	1.36%	100.00K
FIAM Small Cap Core CIT Cl B	1.83M	1.31%	-15.60K
Fidelity Select Biotechnology	1.57M	1.12%	403.00K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 10, 2025	Fairmount Funds Management LLC	-	Buy	$25.00M
Jan 14, 2025	Pinnow Cole	Chief Commercial Officer	Buy	$332.41K
Jun 09, 2023	Fairmount Funds Management LLC	-	Buy	$9.60M
Jun 16, 2022	Fairmount Funds Management LLC		Buy	$9.90M
Apr 26, 2021	Green John L.	Chief Financial Officer	Sell	$157.82K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	1	-
2025 Q2	-	-
2025 Q1	1	-
2024 Q4	-	-

COGT Ownership FAQ

Who Owns Cogent Biosciences?

Cogent Biosciences shareholders are primarily institutional investors at 118.38%, followed by 0.04% insiders and -18.42% retail investors. The average institutional ownership in Cogent Biosciences's industry, Biotech Stocks , is 295.31%, which Cogent Biosciences falls below.

Who owns the most shares of Cogent Biosciences?

Cogent Biosciences’s largest shareholders are Fmr (22.41M shares, 19.58%), Blackrock funding, inc. /de (10.37M shares, 9.06%), and Kynam capital management, lp (8.49M shares, 7.42%). Together, they hold 36.05% of Cogent Biosciences’s total shares outstanding.

Does Blackrock own Cogent Biosciences?

Yes, BlackRock owns 7.34% of Cogent Biosciences, totaling 7.29M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 61.44M$. In the last quarter, BlackRock increased its holdings by 598.76K shares, a 8.95% change.

Who is Cogent Biosciences’s biggest shareholder by percentage of total assets invested?

New leaf venture partners is Cogent Biosciences’s biggest shareholder by percentage of total assets invested, with 8.37% of its assets in 250.76K Cogent Biosciences shares, valued at 3.6M$.

Who is the top mutual fund holder of Cogent Biosciences shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cogent Biosciences shares, with 2.91% of its total shares outstanding invested in 4.06M Cogent Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools